Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo

Cardiovascular Drugs and Therapy

Volumn 13, Issue 2, 1999, Pages 159-168

  Myllärniemi, Marjukka ^a   Frösen, Juhana ^a   Calderón Ramirez, Lázaro G ^a   Buchdunger, Elisabeth ^b   Lemström, Karl ^a   Häyry, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Balloon reinjury; Neointima; PDGF; Receptor tyrosine kinase

Indexed keywords

ANTIMITOTIC AGENT; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; IMATINIB; LIGAND; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOMEDIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA BALLOON; AORTA STENOSIS; ARTERY INJURY; ARTERY INTIMA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CELL DIVISION; CELLS, CULTURED; MALE; MUSCLE, SMOOTH, VASCULAR; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RETREATMENT; TUNICA INTIMA;

EID: 0032907306     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007700629728     Document Type: Article

References (38)

1. 1. Virmani H, Farb A, Burke AP. Coronary angioplasty from the perspective of the atherosclerotic plaque: Morphologic predictors of immediate success and restenosis. Am Heart J 1994;127:163-179.
2. 2. Haudenschild CC. Pathobiology of restenosis after angioplasty. Am J Med 1993;94:40S-44S.
3. 3. Clowes A, Reidy M, Clowes M. Mechanism of stenosis after arterial injury. Lab Invest 1983;49:208-215.
4. 4. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity. Arterioscler Thromb Vasc Biol 1998;18:333-338.
5. 5. Koyama H, Reidy M. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res 1997;80:408-417.
6. 6. Stadius ML, Gown AM, Kernoff K, Schwartz S. Does sequential balloon injury of an artery lead to a different outcome than single injury? An experimental study of angioplasty. Coro Art Dis 1996;7:247-55.
7. 7. Courtman DW, Schwartz S, Hart CE. Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass. Circ Res 1998;82:996-1006.
8. 8. Hart CE, Forstrom JW, Kelly JD, et al. Two classes of PDGF receptor recognize different isoforms of PDGF. Science 1988;240:1529-1531.
9. 9. Heldin C-H, Ernlund A, Rorsman C, Rönnstrand L. Dimerization of B-type platelet derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J Biol Chem 1989;264:8905-912.
10. 10. Ross R, Raines E, Bowen-Pope DF. The biology of platelet derived growth factor. Cell 1986;46:155-169.
11. 11. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschildt CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest 1993;91:1822-1829.
12. 12. Myllärniemi M, Calderon L, Lemström K, Buchdunger E, Häyry P. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J 1997;11:1119-1126.
13. 13. Banai S, Wolf Y, Golomb G, et al. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 1998;97:1960-1969.
14. 14. Lemström KB, Koskinen PK. Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts. Circulation 1997;96:1240-1249.
15. 15. Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Regenass U, Lydon N B. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci USA 1995;92:2558-2562.
16. 16. Buchdunger E, Zimmermann J, Mett H, Meyer T, Mueller M, Druker BJ, Lydon NB. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylalanopyrimidine derivative. Cancer Res 1996;56:100-104.
17. 17. Ross R, Masuda J, Raines EW, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990;248:1009-1012.
18. 18. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93:2178-2187.
19. 19. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990;111:2149-2158.
20. 20. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW, Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invent 1992;89:507-511.
21. 21. Pompili VJ, Gordon D, San H, Yang Z, Muller DWM, Nabel GJ, Nabel EG. Expression and function of a recombinant PDGF B gene in porcine arteries. Artenoscler Thromb Vasc Biol 1995;15:2254-2264.
22. 22. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
23. 23. Sirois MG, Simons M, Edelman ER. Antisense oligonu-cleotide inhibition of PDGFR-β receptor subunit expression directs suppression of intimal thickening. Circulation 1997;95:669-676.
24. 24. Kozai T, Shimokawa H, Fukumoto Y, et al. Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long term treatment with platelet derived factor in pigs in vivo. J Cardiovasc Pharmacol 1997;29:536-545.
25. 25. Maresta A, Balducelli M, Cantini L, et al. For the STARC investigators. Trapidil (triazolopyrimidine), a platelet derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Circulation 1994;90:2710-2915.
26. 26. Carter AJ, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-1405.
27. 27. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. Arterioscler Thromb Vasc Biol 1996;16:34-43.
28. 28. MacLeod DC, Strauss BH, De Jong M, et al. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol 1994;23:59-65.
29. 29. Simari RD, San H, Rekhter M, Ohno T, Gordon D, Nabel GJ, Nabel EG. Regulation of cellular proliferation and intimai formation following baloon injury in atherosclerostic rabbit arteries. J Clin Invest 1996;98:225-235.
30. 30. Schwartz SM, DeBlois D, O'Brien ERM. The intima - soil for atherosclerosis and restenosis. Circ Res 1995;77:445-446.
31. 31. Lemire JM, Covin CW, White S, Giachelli CM, Schwartz S M. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol 1993;144:1069-1081.
32. 32. Calara F, Ameli S, Hultgårdh-Nilsson A, et al. Autocrine induction of DNA synthesis by mechanical injury of cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 1996;16:187-193.
33. 33. Crowley ST, Ray CJ, Nawaz D, Majack RA, Horwitz LD. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 1995;269:H1641-H1647.
34. 34. Rekhter MD, Gordon D. Does platelet derived growth factor stimulate proliferation of arterial mesenchymal cells in atherosclerotic plaques? Circ Res 1994;75:410-417.
35. 35. Levitzki A. Targeting signal transduction for disease therapy. Curr Opin Cell Biol 1996;8:239-244.
36. 36. Panek RL, Dahring TK, Olszewski BJ, Reiser JA. PDGF receptor protein tyrosine kinase expression in the baloon-injured rat carotid artery. Arterioscler Thromb Vasc Biol 1997;17:1283-1288.
37. 37. Major T, Keiser JA. Inhibition of cell growth: Effects of the tyrosine kinase inhibitor CGP 53716. J Pharmacol Exp Ther 1997;283:402-410.
38. 38. Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Ber-Abl positive cells. Nature Med 1996;562-566.